Page last updated: 2024-10-23

atrazine and Atherosclerotic Parkinsonism

atrazine has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, B2
Jiang, Y1
Xu, Y1
Li, Y1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Changes in Serum miRNA and BDNF Levels in Bipolar II Depression Treated by Theta-burst Stimulation: A Randomized Sham-controlled Exploratory Study[NCT04998097]60 participants (Anticipated)Interventional2022-05-23Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for atrazine and Atherosclerotic Parkinsonism

ArticleYear
Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor/α-synuclein axis in atrazine-induced Parkinson's disease by peripheral blood and brain microRNA profiling.
    Chemosphere, 2019, Volume: 233

    Topics: alpha-Synuclein; Animals; Atrazine; Brain; Brain-Derived Neurotrophic Factor; Dopamine; Down-Regulat

2019